- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Melville Today
By the People, for the People
Henry Schein to Reduce Board Size After 2026 Annual Meeting
The dental and medical supply company plans to trim its board from 12 to 9 directors.
Apr. 8, 2026 at 12:43pm
Got story updates? Submit your updates here. ›
Henry Schein, Inc., a leading provider of health care products and services to office-based dental and medical practitioners, announced that it will reduce the size of its Board of Directors from 12 to 9 members following the company's 2026 Annual Meeting of Stockholders.
Why it matters
The move to reduce the board size is part of Henry Schein's ongoing efforts to optimize its corporate governance structure and align with best practices. Smaller boards can often make decisions more efficiently, which could benefit the company as it navigates industry changes and growth opportunities.
The details
The company stated that the reduction in board size will be achieved through attrition as current directors' terms expire, rather than through immediate removals. Henry Schein's Nominating and Governance Committee will oversee the transition to the smaller board.
- The changes will take effect following Henry Schein's 2026 Annual Meeting of Stockholders.
The players
Henry Schein, Inc.
A leading provider of health care products and services to office-based dental and medical practitioners.
The takeaway
The reduction in board size reflects Henry Schein's commitment to streamlining its corporate governance structure and aligning with industry best practices, which could enhance the company's agility and decision-making as it navigates a rapidly evolving health care landscape.


